Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Year range
1.
IJRM-International Journal of Reproductive Biomedicine. 2018; 16 (6): 365-372
in English, Persian | IMEMR | ID: emr-199225

ABSTRACT

Background: Prescribing antidepressant drugs is becoming common. These drugs are known to affect sexual functions


Objective: The study is aimed to assess the effects of amitriptyline and venlafaxine on sperm parameters and evaluate Malondialdehyde [MDA] and 1, 1-Diphenyl-2- picryl-hydrazyl values in BALB/ mice spermatozoa


Materials and Methods: Forty adult male BALB/c mice were separated into five groups. Group I [control] received distilled water; group II amitriptyline [4 mg/kg]; group III amitriptyline [4 mg/kg] +vitamin C [10 mg/kg]; group IV venlafaxine [2 mg/kg]; and group V received vitamin C [10 mg/kg] + venlafaxine [2 mg/kg]. All drugs were administered by oral gavage for 35 days. After excision of caudal epididymis, it was located in 1 mL Ham's F10 medium at 37 degree C for 15 min and then analysis of sperm parameters was performed. To examine lipid peroxidation and total antioxidant capacity, the MDA and 1, 1-Diphenyl-2-picryl-hydrazyl were measured, respectively


Results: The mean sperm parameters in the group treated with amitriptyline were significantly lower than in the other groups. MDA tests showed a significant difference between amitriptyline and control groups [p=0.007]


Conclusion: The results of this study showed that amitriptyline consumption can weaken sperm parameters, which can be attributed to the increased production of ROS and toxicity resulting from amitriptyline consumption. Moreover, venlafaxine improved sperm parameters in mice and the lipid peroxidation in this group did not change compared to the control group

SELECTION OF CITATIONS
SEARCH DETAIL